ThyCa Medullary Thyroid Cancer Research Fund
Funding Amount
Varies
Deadline
Rolling / Open
Grant Type
foundation
Overview
ThyCa Medullary Thyroid Cancer Research Fund
Funder: ThyCa: Thyroid Cancer Survivors' Association, Inc.
Geographic Scope: International; open to researchers and institutions worldwide
Focus Areas: Research specifically focused on medullary thyroid cancer, including:
Program Overview:
ThyCa established the Medullary Thyroid Cancer Research Fund in 2003 as a second research fund to support research on medullary thyroid cancer specifically. Medullary thyroid cancer accounts for 5-10% of all thyroid cancer cases and has unique features distinct from follicular-cell-derived thyroid cancers.
- Dedicated Focus: Specialized research fund separate from the general Thyroid Cancer Research Fund
- Funding Structure: 100% of donated funds go directly to research
- Selection Process: Independent peer review by expert scientific panel of the American Thyroid Association (ATA)
- Grant Terms: Typically 2-year grants with continuation funding based on progress reports
- Tax Deductible: All contributions are tax-deductible to the extent allowed by IRS
Key Features
- Open to researchers at any hospital or research institution
- International researchers eligible
- Research proposals evaluated on scientific merit regardless of institution affiliation
Eligibility
- Donors may designate contributions specifically to the Medullary Thyroid Cancer Research Fund
- Donors may also contribute to both the Medullary Thyroid Cancer Fund and the Thyroid Cancer Research Fund
- Contributions of any size welcome
Donor Options
- Phone: 1-877-588-7904
- Email: thyca@thyca.org
- Mailing Address: ThyCa: Thyroid Cancer Survivors' Association, Inc., Research Fund, PO Box 1545, New York, NY 10159-1545
- Website: www.thyca.org
Contact Information
- 2005/2007: Matthias Schott, M.D., Heinrich-Heine University of Duesseldorf, Germany - "Induction of Cytotoxic Immunity in Medullary Thyroid Carcinoma by Dendritic Vaccination"
- 2006/2007: Xianmin Xia, Ph.D., Johns Hopkins University School of Medicine, Baltimore, Maryland - Research on tumor suppressor proteins affecting medullary thyroid cancer cells
Notable Recipients
How to Apply
Application Process
Applications are submitted through the American Thyroid Association (ATA) portal:
1. Visit: www.thyroid.org or the ATA professionals/education/grants section
2. Submit Proposal Summary by announced deadline (e.g., March 15, 2005 for 2005 cycle)
3. Selected Proposals: Authors invited to submit complete grant applications (typically due in spring)
4. Expert Review: Scientific panel of the ATA conducts independent peer review
5. Award Decision: Based on scientific merit and relevance to medullary thyroid cancer research
- Initial proposal summary
- Complete grant application (if selected)
- Progress reports (required in fourth quarter of first year for continuation funding)
Required Materials
- Check ATA website for current application deadlines and specific guidelines
- Applications open to researchers worldwide
- ThyCa coordinates with ATA for all review and selection processes
- Focus must be specifically on medullary thyroid cancer research
Notes
Focus Areas & Funding Uses
Fields of Work
Categories
Browse similar grants by category
Related Grants
Similar grants from this funder and related organizations
Nemaline Myopathy Research Grants (RFA)
Amount
Up to $100,000 per year for up to three years (up to five grants available)
Deadline
Rolling / Open
WAM Research Grant Program
Amount
Varies
Deadline
Rolling / Open
Paul E. Strandjord Young Investigator Grant
Amount
$7,500
Deadline
December 12, 2026
Jonas Environmental Health Education Project
Amount
$435,000
Deadline
Rolling / Open
Michelson Prizes: Next Generation Grants
Amount
$150,000
Deadline
Rolling / Open
BMS Small Grant
British Mycological Society
Amount
Up to £500
Deadline
Rolling / Open
Ready to apply for ThyCa Medullary Thyroid Cancer Research Fund?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.